A prospective study comparing injectable interferon beta-1a (Rebif 22-44), (Avonex 30) and 1b (Betaseron 250) injection site reaction in multiple sclerosis patients
Foziah Alshamrani, H. Alnajashi, Fahad A. Alkhamis, I. Alghanimi, Abdulla AlSulaiman, Aisha AlBaker, Iqbal bukari, Amir Mohamad
{"title":"A prospective study comparing injectable interferon beta-1a (Rebif 22-44), (Avonex 30) and 1b (Betaseron 250) injection site reaction in multiple sclerosis patients","authors":"Foziah Alshamrani, H. Alnajashi, Fahad A. Alkhamis, I. Alghanimi, Abdulla AlSulaiman, Aisha AlBaker, Iqbal bukari, Amir Mohamad","doi":"10.19082/7574","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11603,"journal":{"name":"Electronic Physician","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Electronic Physician","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19082/7574","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
